Posted in | Bionanotechnology

Bruker's MALDI Biotyper Chosen by AGES for Microbial Analyses

Published on May 17, 2010 at 5:04 AM

At the 32rd OEGHMP annual meeting (“Jahrestagung der Österreichischen Gesellschaft für HYGIENE, MIKROBIOLOGIE und PRÄVENTIVMEDIZIN”) opening here today, Bruker announces that its MALDI Biotyper workflow for microbial identification in clinical microbiology has been selected by the Austrian Agency for Health and Food Safety (AGES) for MALDI-TOF based analyses of microorganisms.

Bruker's dedicated MALDI Biotyper system enables molecular identification, taxonomical classification or dereplication of microorganisms like bacteria, yeasts and fungi.

AGES is responsible for several tasks in regard to public health and food safety for the Austrian government. The organization researches, analyzes and performs inspections according to the policy guidelines of Austrian Food Laws. The agency requires veterinary inspections and dedicates itself to the prevention and control of infectious diseases in the population. Just recently, scientists of the AGES discovered the source of a listeriosis outbreak in Austria and Germany that caused eight deaths due to contaminated cheese products. In order to provide always state of the art microbiological analyses AGES is the first organization in Austria using the IVD-CE marked IVD MALDI Biotyper system that is in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC.

University Professor Dr. med. Franz Allerberger, Head of the Human Medicine Division, AGES commented: “Microbial analyses based on MALDI-TOF mass spectrometry as a molecular identification tool provide premium information in order to describe and differentiate microorganisms very reliably. With advantages in speed, accuracy and cost per sample over phenotypic standard tests, the MALDI Biotyper has the potential to become a new clinical standard for microbial identification. In particular, for fastidious microorganisms like anaerobic and non-fermenting bacteria the superior discrimination power of the MALDI Biotyper has been proven in several publications. In order to substantiate the MALDI Biotyper benefit especially for difficult species in the daily clinical routine AGES will be the leading organization for quality assurance and standardization for the analysis after Legionella infections. In this context we will also perform a respective round robin test comprising labs from all over the world.”

Dr. Guido Mix, Bruker Daltonics Director for Microbiology Business Development, concluded: “The MALDI Biotyper is already a very suitable and reliable tool for daily microbiological routine analysis. Globally more than 100 clinical diagnostic labs, as well as further microbiology departments at industrial and academic sites operate this protein fingerprinting-based approach. We are very pleased to collaborate with an organization like the AGES in order to explore the MALDI Biotyper capabilities beyond current standardized operational species identification procedures, and towards strain typing or clone tracking.”


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback